Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 149   

Articles published

GSK 1,697.50 -13.50 (-0.79%)
price chart
Form SD GLAXOSMITHKLINE PLC
GlaxoSmithKline plc (together with its consolidated subsidiaries, “GSK”) is a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas: Pharmaceuticals, Vaccines and Consumer ...
As Glaxosmithkline Plc (GSK) Market Value Rose, Park Circle Co Has Lifted ...
Peter S. Park increased its stake in Glaxosmithkline Plc (GSK) by 44.86% based on its latest 2016Q4 regulatory filing with the SEC.
Investors Are Circling GlaxoSmithKline plc (LSE:GSK), What Do the Numbers Tell Us?
The Shareholder Yield of GlaxoSmithKline plc (LSE:GSK) is 4.37%. The Shareholder Yield is a way that investors can see how much money shareholders are receiving from a company through a combination of dividends, share repurchases and debt ...
GlaxoSmithKline PLC (GSK) Stake Increased by Anchor Capital Advisors LLC
GlaxoSmithKline PLC logo Anchor Capital Advisors LLC increased its position in GlaxoSmithKline PLC (NYSE:GSK) by 9.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Fayez Sarofim & Co Cuts Stake in GlaxoSmithKline PLC (GSK)  BNB Daily (blog)
Camelot Portfolios Has Trimmed Glaxosmithkline Plc (Gsk) (GSK) Position, 8 ...  FlintDaily.com
Did GlaxoSmithKline plc (LSE:GSK) Create Value For Shareholders?
While GlaxoSmithKline plc's (LSE:GSK) 31.9% ROE was above the industry average of 20.6%, the role of leverage must also be considered.
What Will Happen to Glaxosmithkline Plc (NYSE:GSK) Next? The Stock Has ...  KL Daily
GlaxoSmithKline plc (GSK) PT Set at GBX 1700 by Morgan Stanley  The Cerbat Gem
Today Liberum Capital Reaffirms a “Buy” Rating on GlaxoSmithKline PLC (LON:GSK ...
In a note revealed to investors this morning, Liberum Capital restate their “Buy” rating on GlaxoSmithKline PLC (LON:GSK) shares.
Analyst at Shore Capital Keeps The GlaxoSmithKline PLC (LON:GSK) Hold Rating ...  KL Daily
Diphtheria – Market Analysis, H1 2017 With Key Vendors GlaxoSmithKline Plc ...
HTF Market Intelligence released a new research report of 68 pages on title 'Diphtheria - Pipeline Review, H1 2017' with detailed analysis, forecast and strategies.
EPS for GlaxoSmithKline plc (ADR) (GSK) Expected At $0.71, 1 Analysts Covering ...
Analysts expect GlaxoSmithKline plc (ADR) (NYSE:GSK) to report $0.71 EPS on July, 26.They anticipate $0.01 EPS change or 1.43% from last quarter's $0.7 EPS.
Active Runner in Focus: GlaxoSmithKline PLC (GSK.L)
Shares of GlaxoSmithKline PLC (GSK.L) are moving on volatility today 0.26% or 4.50 from the open. The LSE listed company saw a recent bid of 1713.00 and 957086 shares have traded hands in the session.
Haverford Trust Company Decreased Glaxosmithkline Plc (GSK) Stake; Sharps ...
Haverford Trust Company decreased Glaxosmithkline Plc (GSK) stake by 3.48% reported in 2016Q4 SEC filing. Haverford Trust Company sold 24,368 shares as Glaxosmithkline Plc (GSK)'s stock rose 5.47%. The Haverford Trust Company holds 675,189 ...